• Je něco špatně v tomto záznamu ?

Kontrola srdeční frekvence versus kontrola rytmu u nemocných se srdečním selháním [Rhythm control versus rate control for atrial fibrillation and heart failure]

Denis Roy, et al.

. 2008 ; 2 (5) : 37-38.

Jazyk angličtina Země Česko

Perzistentní odkaz   https://www.medvik.cz/link/bmc07521984

It is common practice to restore and maintain sinus rhythm in patients with atrial fibrillation and heart failure. This approach is based in part on data indicating that atrial fibrillation is a predictor of death in patients with heart failure and suggesting that the suppression of atrial fibrillation may favorably affect the outcome. However, the benefits and risks of this approach have not been adequately studied. METHODS: We conducted a multicenter, randomized trial comparing the maintenance of sinus rhythm (rhythm control) with control of the ventricular rate (rate control) in patients with a left ventricular ejection fraction of 35% or less, symptoms of congestive heart failure, and a history of atrial fibrillation. The primary outcome was the time to death from cardiovascular causes. RESULTS: A total of 1376 patients were enrolled (682 in the rhythm-control group and 694 in the rate-control group) and were followed for a mean of 37 months. Of these patients, 182 (27%) in the rhythm-control group died from cardiovascular causes, as compared with 175 (25%) in the rate-control group (hazard ratio in the rhythm-control group, 1.06; 95% confidence interval, 0.86 to 1.30; P=0.59 by the log-rank test). Secondary outcomes were similar in the two groups, including death from any cause (32% in the rhythm-control group and 33% in the rate-control group), stroke (3% and 4%, respectively), worsening heart failure (28% and 31%), and the composite of death from cardiovascular causes, stroke, or worsening heart failure (43% and 46%). There were also no significant differences favoring either strategy in any predefined subgroup. CONCLUSIONS: In patients with atrial fibrillation and congestive heart failure, a routine strategy of rhythm control does not reduce the rate of death from cardiovascular causes, as compared with a rate-control strategy. (ClinicalTrials.gov number, NCT00597077.) 2008 Massachusetts Medical Society

Rhythm control versus rate control for atrial fibrillation and heart failure

000      
00000naa 2200000 a 4500
001      
bmc07521984
003      
CZ-PrNML
005      
20111210133041.0
008      
090423s2008 xr e eng||
009      
AR
040    __
$a ABA008 $b cze $c ABA008 $d ABA008 $e AACR2
041    0_
$a eng $b cze
044    __
$a xr
100    1_
$a Roy, Denis
245    10
$a Kontrola srdeční frekvence versus kontrola rytmu u nemocných se srdečním selháním / $c Denis Roy, et al.
246    11
$a Rhythm control versus rate control for atrial fibrillation and heart failure
314    __
$a Montreal Heart Institute and the Université de Montréal, Montréal
520    9_
$a It is common practice to restore and maintain sinus rhythm in patients with atrial fibrillation and heart failure. This approach is based in part on data indicating that atrial fibrillation is a predictor of death in patients with heart failure and suggesting that the suppression of atrial fibrillation may favorably affect the outcome. However, the benefits and risks of this approach have not been adequately studied. METHODS: We conducted a multicenter, randomized trial comparing the maintenance of sinus rhythm (rhythm control) with control of the ventricular rate (rate control) in patients with a left ventricular ejection fraction of 35% or less, symptoms of congestive heart failure, and a history of atrial fibrillation. The primary outcome was the time to death from cardiovascular causes. RESULTS: A total of 1376 patients were enrolled (682 in the rhythm-control group and 694 in the rate-control group) and were followed for a mean of 37 months. Of these patients, 182 (27%) in the rhythm-control group died from cardiovascular causes, as compared with 175 (25%) in the rate-control group (hazard ratio in the rhythm-control group, 1.06; 95% confidence interval, 0.86 to 1.30; P=0.59 by the log-rank test). Secondary outcomes were similar in the two groups, including death from any cause (32% in the rhythm-control group and 33% in the rate-control group), stroke (3% and 4%, respectively), worsening heart failure (28% and 31%), and the composite of death from cardiovascular causes, stroke, or worsening heart failure (43% and 46%). There were also no significant differences favoring either strategy in any predefined subgroup. CONCLUSIONS: In patients with atrial fibrillation and congestive heart failure, a routine strategy of rhythm control does not reduce the rate of death from cardiovascular causes, as compared with a rate-control strategy. (ClinicalTrials.gov number, NCT00597077.) 2008 Massachusetts Medical Society
650    _2
$a beta blokátory $x terapeutické užití $7 D000319
650    _2
$a senioři $7 D000368
650    _2
$a amiodaron $x terapeutické užití $7 D000638
650    _2
$a inhibitory ACE $x terapeutické užití $7 D000806
650    _2
$a antiarytmika $x terapeutické užití $7 D000889
650    _2
$a fibrilace síní $x prevence a kontrola $7 D001281
650    _2
$a kardiovaskulární nemoci $x mortalita $7 D002318
650    _2
$a kombinovaná terapie $7 D003131
650    _2
$a digitalisové glykosidy $x terapeutické užití $7 D004071
650    _2
$a elektrická defibrilace $7 D004554
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a následné studie $7 D005500
650    _2
$a srdeční selhání $x farmakoterapie $x komplikace $x terapie $7 D006333
650    _2
$a srdeční frekvence $7 D006339
650    _2
$a hospitalizace $x statistika a číselné údaje $7 D006760
650    _2
$a lidé $7 D006801
650    _2
$a Kaplanův-Meierův odhad $7 D053208
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    _2
$a prospektivní studie $7 D011446
650    _2
$a dysfunkce levé srdeční komory $7 D018487
773    0_
$w MED00012706 $t Clinical cardiology alert $g Roč. 2, č. 5 (2008), s. 37-38 $x 1213-2586
787    18
$w bmc07521985 $i Recenze v: $t Komentář [Kontrola srdeční frekvence versus kontrola rytmu u nemocných se srdečním selháním]
910    __
$a ABA008 $b B 2242 $c 407 a $y 9
990    __
$a 20090423080915 $b ABA008
991    __
$a 20090601112153 $b ABA008
999    __
$a ok $b bmc $g 645073 $s 497989
BAS    __
$a 3
BMC    __
$a 2008 $b 2 $c 5 $d 37-38 $i 1213-2586 $m Clinical Cardiology Alert $x MED00012706
LZP    __
$a 2009-15/mkme

Najít záznam

Citační ukazatele

Nahrávání dat ...

    Možnosti archivace